Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Hemagen Diagnostics Inc (HMGN) since 2011 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Hemagen Diagnostics Inc. Table 2 shows the detailed insider transactions. This company's CIK number is 892822.
Total stock buying since 2011: $524.
Total stock sales since 2011: $0.
Total stock option exercises since 2011: $0.
▪ Recent SEC 13D filings for all companies
▪ Recent portfolio reports of all companies
| Insider Buying | Insider Sales | Option Exercises | ||||
|---|---|---|---|---|---|---|
| Year | Shares | Value | Shares | Value | Shares | Value |
| 2012 | 10,800 | $259 | 0 | $0 | 0 | $0 |
| 2011 | 5,300 | $265 | 0 | $0 | 0 | $0 |
| Trading Period | Insider Buying | Insider Sales | Option Exercises | |||
|---|---|---|---|---|---|---|
| year-month | Shares | Value | Shares | Value | Shares | Value |
| 2012-07 | 10,800 | $259 | 0 | $0 | 0 | $0 |
| 2011-04 | 5,300 | $265 | 0 | $0 | 0 | $0 |
| Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2012-07-31 | Hales William P (Chairman, President & CEO) | Buy | 10,800 | .02 | 259 |
| 2011-04-06 | Hales William P (Chairman, President & CEO) | Buy | 5,300 | .05 | 265 |
Insider trading activities including stock purchases, stock sales, and option exercises of HMGN listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Hemagen Diagnostics Inc (symbol HMGN, CIK number 892822) see the Securities and Exchange Commission (SEC) website.